Search

everythinglearnresearchcommunity

for

Search:↓

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

ANE syndrome is caused by a mutation in the RBM28 protein that disrupts ribosome assembly.

Managing recurrent painless thyroiditis is challenging and should be personalized based on episode frequency, severity, symptoms, and patient preferences.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

HIV can cause various nail and hair disorders, important for early diagnosis and treatment.

A dog in Colorado was diagnosed with leishmaniasis, suggesting the disease might be present in the state.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

Sulfasalazine may help treat persistent alopecia areata.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Patients and doctors often disagree on alopecia areata severity and treatment satisfaction.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Symmetrical Acrokeratoderma (SAK) may be a unique skin condition in China, lacking specific treatment and needing long-term monitoring.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Vitamin D levels are not linked to Alopecia Areata.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

PRP injections can effectively improve knee osteoarthritis symptoms.

Testing for the NUDT 15 variant is crucial before starting azathioprine, especially in Asians.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Anti-TNF therapy can cause hair loss and skin issues.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.